Appointment booking for Dr. Jenson Abraham, MD is currently not available.Dr. Jenson Abraham, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Jenson Abraham, MD (he/him) is a Internist in Bryn Mawr, PA with over 15 years of experience. What is your opinion of Dr. Jenson Abraham, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 15 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Jenson Abraham, MD has received over $1,529 which includes payments from the following companies:
$320.50 from Merck Sharp & Dohme Corporation
$266.86 from Pfizer Inc.
$235.06 from Janssen Pharmaceuticals, Inc
$140.44 from E.R. Squibb & Sons, L.L.C.
$125.97 from AstraZeneca Pharmaceuticals LP
$86.69 from Mylan Specialty L.P.
$83.01 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$47.01 from Actavis Pharma Inc
$36.76 from EKOS Corporation
$36.72 from Medtronic Vascular, Inc.
$34.21 from Sunovion Pharmaceuticals Inc.
$30.92 from BTG International, Inc.
$24.32 from Medtronic USA, Inc.
$18.33 from Novo Nordisk Inc
$16.11 from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$13.90 from Smith & Nephew, Inc.
$12.43 from Otsuka America Pharmaceutical, Inc.
Payments received by Dr. Jenson Abraham, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!